![](/img/cover-not-exists.png)
Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer
Schwartz, Naomi R.M., Flanagan, Meghan R., Babigumira, Joseph B., Steuten, Lotte M., Roth, Joshua A.Volume:
25
Journal:
Journal of Managed Care & Specialty Pharmacy
DOI:
10.18553/jmcp.2019.25.10.1133
Date:
October, 2019
File:
PDF, 251 KB
2019